Compounded pain relief creams

Additional information

Compounded pain relief creams

Pain rarely fits one off-the-shelf concentration. When standard topicals haven’t been enough, compounded pain relief creams give your prescriber the room to build something around your specific pain pattern, your skin, and your wider medical history. Pain management built around you, not the other way round.

If you’ve worked your way through paracetamol, oral ibuprofen, Voltarol Emulgel, and maybe a co-codamol or two, and you’re still uncomfortable in the same shoulder, knee, hand, or lower back you were uncomfortable in three months ago, you’re not alone, and you’re not at the end of the road. Compounded pain relief creams are bespoke topical medicines, mixed in a UK-licensed compounding pharmacy to a prescription written specifically for one patient. They allow your prescriber to choose the active ingredients, concentrations, combinations, and base, rather than picking the closest match off the shelf. At Courier Pharmacy, we treat pain prescribing the way we treat any long-term condition: with a real conversation, a real prescriber, and real follow-up. Healthcare that fits you, not the other way round.

Five key takeaways

• Compounded pain relief creams are personalised topical medicines, prescribed by a UK-qualified prescriber and mixed by a UK-licensed compounding partner around the individual patient.
• Common active ingredients include diclofenac at concentrations up to 5% (considerably higher than the 1.16% in commercial Voltarol Emulgel), lidocaine at 2% to 10%, ketoprofen, ibuprofen, piroxicam, amitriptyline, menthol, capsaicin, clonidine, baclofen, and cyclobenzaprine.
• Combination creams (e.g. diclofenac plus lidocaine, or lidocaine plus amitriptyline plus menthol) work better than single agents for mixed-mechanism pain, where inflammation, nerve sensitisation, and muscle spasm all contribute.
• Topical delivery substantially reduces gastrointestinal, renal, and cardiovascular exposure compared with oral NSAIDs, which is why NICE’s NG226 osteoarthritis guideline recommends topical NSAIDs as a first-line pharmacological option for hand and knee osteoarthritis.
• Compounded creams are a Prescription Only Medicine, not an off-the-shelf product. They’re a considered second or third step for patients whose pain genuinely needs more than the standard pathway can provide, not a routine first move.

What you should know about compounded pain relief creams

Most patients don’t need a compounded cream as their first move. For acute, mild, or moderate localised pain, the right starting point is usually a combination of conservative measures (rest, ice, activity modification, physiotherapy where appropriate), simple analgesia (paracetamol, ibuprofen), and an off-the-shelf topical NSAID such as Voltarol Emulgel. The NHS and NICE Clinical Knowledge Summaries on analgesia consistently support this stepped approach as the safest, most evidence-based starting point.

A compounded cream becomes the right conversation when standard options have been tried properly and haven’t been enough. The framework we use looks like this. First, make sure the diagnosis is right. Second, treat any reversible underlying cause (an iron deficiency, an inflammatory condition requiring disease-modifying treatment, an undiagnosed mechanical issue). Third, escalate from off-the-shelf to compounded only when there’s a clinical reason to do so. Fourth, review the formulation at 4 to 6 weeks and refine it. That four-step approach is the difference between a useful prescription and an expensive guess.

Compounded pain relief creams overview

Persistent localised pain is one of the most common reasons adults seek pharmacy advice in the UK, and one of the conditions where the gap between “what’s available” and “what’s right for me” is widest. The NHS estimates that around one in three adults in the UK lives with chronic pain in some form, and NICE Clinical Knowledge Summaries on analgesia note that response to standard analgesics is highly variable between individuals.

That variability is exactly the problem compounded pain relief creams are designed to solve. Off-the-shelf topical NSAIDs come at one or two concentrations, in one or two vehicles, with a fixed list of excipients. For some patients, that’s a perfect match. For others, the concentration is too low to reach the affected tissue at a clinically meaningful level. For others, excipients (propylene glycol, alcohol, parabens, lanolin, fragrance) cause skin reactions, so even an effective active ingredient can’t be tolerated. And for many patients with persistent pain, the underlying biology isn’t a single mechanism, so a single-mechanism medicine only ever addresses part of the picture.

Compounded creams give the prescriber room to address those gaps. A higher diclofenac concentration. A lidocaine layer for the surface neuropathic component. A muscle relaxant for the spasm element. A stripped-back base for sensitive skin. None of this is exotic. It’s evidence-led personalisation, built on the same pharmacology as standard topical analgesics, applied with more flexibility.

The diagnostic and treatment landscape can be difficult to navigate alone. Many patients spend months or years on rotating standard products without realising that compounded options exist, that they require prescriber assessment, and that they sit firmly within UK-regulated pharmacy practice when supplied through a registered, licensed compounding pathway. The Royal Pharmaceutical Society and the General Pharmaceutical Council both recognise compounded medicines as a legitimate part of UK pharmacy when prescribed and prepared appropriately.

What are compounded pain relief creams?

Compounded pain relief creams are personalised topical analgesic medicines, mixed in a UK-licensed compounding pharmacy to a prescription written by a UK-qualified prescriber for one specific patient. The prescription specifies the active ingredients, their concentrations, the combination, and the base (cream, gel, ointment, or specialist vehicle), based on the individual patient’s pain pattern, skin, and medical history. The General Pharmaceutical Council regulates UK compounding pharmacies in the same way it regulates any other dispensing pharmacy, and prescribers are bound by the same professional standards that apply to all UK prescribing.

A compounded cream might address the following kinds of localised pain:

• Persistent osteoarthritic pain (knee, hand, shoulder) that hasn’t responded to standard topical NSAIDs
• Localised musculoskeletal pain in patients who can’t tolerate or shouldn’t take oral NSAIDs
• Mixed inflammatory and neuropathic pain (e.g. post-injury pain with persistent burning, tingling, or pins and needles)
• Post-surgical or post-traumatic pain in a defined area
• Localised neuropathic pain (post-herpetic neuralgia, focal small-fibre neuropathy, persistent localised nerve pain)
• Localised muscle-spasm-driven pain (tension-pattern lower back, persistent shoulder spasm)
• Pain in patients with significant skin sensitivities or excipient intolerances who can’t use commercial preparations
• Pain in patients living with fibromyalgia, hypermobility, or persistent musculoskeletal pain in the context of a complex medical history

How common is the underlying need?

Persistent pain is genuinely common. The NHS reports that around one in three adults in the UK lives with chronic pain in some form, and prevalence rises significantly with age. Knee osteoarthritis alone affects approximately 18% of adults over 45 in the UK. Persistent localised musculoskeletal pain (back, neck, shoulder, hand) is one of the most common reasons adults consult primary care.

Despite this prevalence, compounded options remain underused. Most patients reach them only after years of cycling through standard products. According to NICE Clinical Knowledge Summaries on analgesia, response to standard topical and oral analgesics is highly variable between individuals, which is precisely the gap that compounded prescribing addresses. The challenge isn’t that compounded creams are rare in clinical practice. It’s that most patients aren’t told they exist.

What drives the need for compounded pain creams?

When off-the-shelf concentrations aren’t enough

Voltarol Emulgel at 1.16% (11.6mg/g) is a strong starting point for many patients. For others, particularly those with deeper tissue involvement, a higher concentration can produce more reliable local effect. Diclofenac at 5% in a compounded base is one of the most commonly prescribed step-up options, used where a 1.16% topical hasn’t been enough after a fair trial of two weeks or more.

When the pain has more than one mechanism

Persistent pain rarely comes from a single source. A long-standing knee problem typically combines local inflammation (NSAID-responsive), peripheral nerve sensitisation (lidocaine-responsive), and sometimes muscle spasm (baclofen or cyclobenzaprine-responsive). A single-mechanism medicine only ever covers part of the picture. Compounded combinations allow the prescriber to address two or three mechanisms in a single cream.

When excipients are the problem

Some patients can’t tolerate standard topical preparations because of the excipients rather than the active ingredient. Propylene glycol, alcohol, parabens, lanolin, and certain fragrances are common culprits. For patients with eczema, contact dermatitis, MCAS, or sensitive skin in general, a stripped-back compounded base can mean the difference between a workable treatment and one that has to be abandoned. MCAS care that takes you seriously means thinking about excipients, not just actives.

When oral options aren’t suitable

Oral NSAIDs carry well-documented gastrointestinal, renal, and cardiovascular risks. Older patients, patients with chronic kidney disease, patients on anticoagulants, patients on multiple cardiovascular medicines, and patients with a history of gastric ulceration often can’t take oral NSAIDs at all. Topical compounded NSAIDs deliver clinically meaningful local concentrations with substantially lower systemic exposure, which is why NICE’s NG226 osteoarthritis guideline puts topical NSAIDs ahead of oral NSAIDs for hand and knee osteoarthritis.

When the goal is to reduce opioid use

For patients on long-term oral opioids for persistent pain, compounded topical creams can provide enough additional pain control to allow gradual opioid reduction. The Faculty of Pain Medicine’s Opioids Aware programme and the British Pain Society both highlight multimodal pain management as a key strategy in reducing long-term opioid prescribing, and compounded topicals are part of that toolkit.

What happens in the body when compounded pain creams are applied?

Pain isn’t one signal. It’s a system. Local tissue damage triggers inflammatory mediators, including prostaglandins, which sensitise pain receptors and amplify signal transmission. Peripheral nerves can become sensitised by repeated stimulation, lowering the threshold at which they fire. The spinal cord can amplify those signals (central sensitisation). Local muscle spasm can compress structures and produce its own pain.

A compounded pain cream addresses these layers locally. NSAIDs (diclofenac, ketoprofen, ibuprofen, piroxicam) inhibit cyclooxygenase enzymes, reducing prostaglandin production in inflamed tissue. Local anaesthetics (lidocaine, tetracaine) block voltage-gated sodium channels in peripheral nerves, dampening pain signal transmission at the surface. Topical neuropathic agents (amitriptyline) modulate nerve excitability locally. Counter-irritants (menthol, capsaicin) act on TRPM8 and TRPV1 receptors, respectively, modulating pain perception through sensory pathways. Muscle relaxants (cyclobenzaprine, baclofen) reduce local muscle spasm.

Crucially, all of this happens at the application site, with substantially lower systemic absorption than equivalent oral doses. The British National Formulary notes that topical NSAID systemic exposure is typically a small fraction of that with oral NSAIDs, which is why the gastrointestinal, renal, and cardiovascular adverse-effect profile of topical NSAIDs is closer to placebo than to oral NSAIDs in clinical trials.

Diagnosing the right candidate for a compounded pain cream

Compounded pain creams aren’t a diagnosis. They’re a treatment for a clearly defined pain problem in a clearly defined patient. The first step is making sure the underlying diagnosis is right. That usually means a structured history (where, when, what kind, what makes it better and worse), a physical examination where appropriate, and any imaging or blood tests indicated by the picture. NICE Clinical Knowledge Summaries on analgesia and on chronic pain emphasise the importance of identifying the pain mechanism (nociceptive, inflammatory, neuropathic, mixed) before choosing a treatment.

For patients who consult Courier Pharmacy directly, our online consultation captures the pain pattern, previous treatments, current medications, allergies, and goals. Our prescriber reviews the answers, often with a follow-up message or call, and decides whether a compounded approach is the right next step or whether something else (a referral, a blood panel, a different oral medicine, a return to first-line topical options at the right dose for the right duration) would serve you better.

Where blood tests are clinically appropriate, Courier Pharmacy can arrange them as part of the consultation. Common panels include full blood count, ESR or CRP if inflammatory pain is suspected, ferritin, thyroid function, vitamin D, and HbA1c, depending on the clinical picture. Tests that answer the question, not just tick a box.

Managing pain with compounded creams: current options

Single-active NSAID compounded creams

Diclofenac at 3%, 5%, or higher (depending on the prescriber’s clinical judgement and the patient’s previous response) is the most commonly prescribed compounded NSAID cream. Ketoprofen, ibuprofen, and piroxicam are alternatives for patients who haven’t tolerated diclofenac. The British National Formulary and NICE NG226 both recognise topical NSAIDs as effective options for localised inflammatory pain.

Lidocaine creams and gels

Topical lidocaine at 2% to 10% can be used as a single agent for surface neuropathic pain, post-herpetic neuralgia, and certain localised soft tissue presentations. Lidocaine 5% medicated plasters are licensed for post-herpetic neuralgia in the UK; compounded lidocaine creams give prescribers more flexibility for off-label use in other localised pain presentations.

NSAID plus lidocaine combinations

A diclofenac 5% plus lidocaine 5% combination cream is one of the most common compounded options for mixed inflammatory and surface neuropathic pain. The NSAID addresses the inflammatory component; the lidocaine addresses the surface nerve component. Both work locally with minimal systemic exposure.

Triple-mechanism creams

For more complex chronic pain, prescribers may combine three active ingredients in one cream. Common formulations include lidocaine plus amitriptyline plus menthol for chronic localised neuropathic pain, or diclofenac plus lidocaine plus baclofen for mixed inflammatory and muscle-spasm pain. These triple combinations are particularly useful for patients with persistent pain who would otherwise need multiple separate products.

Specialist neuropathic creams

For carefully selected patients with chronic neuropathic pain who haven’t responded to standard oral neuropathic agents, compounded topical amitriptyline can provide additional benefit. These are specialist-supervised options and are not appropriate as a first-line move.

Excipient-free and stripped-back bases

For patients with significant skin sensitivities, MCAS, eczema, or contact dermatitis, the base matters as much as the active. Compounded creams can be formulated without propylene glycol, alcohol, parabens, lanolin, or fragrances, using vehicles specifically chosen for skin tolerability.

Lifestyle measures alongside compounded creams

A compounded cream is rarely the whole answer. The British Pain Society and NICE both recommend multimodal pain management for persistent pain, combining pharmacological treatment with physiotherapy, activity modification, weight management where relevant, sleep optimisation, and, where appropriate, psychological approaches such as pain-focused cognitive behavioural therapy. A good compounded cream supports a good plan; it doesn’t replace one.

Patient experiences and challenges

The most common thing we hear from patients exploring compounded pain creams is some version of “I had no idea this existed.” That’s not an individual failing; it’s a system gap. UK pharmacy education focuses heavily on commercially manufactured medicines, and many GPs and patients aren’t routinely told that compounded options are within the scope of regulated UK pharmacy practice as a legitimate prescribing route.

Two misunderstandings often come up. The first is that compounded creams are somehow less regulated or less safe than commercial products. They aren’t. Compounding pharmacies in the UK are licensed and regulated by the General Pharmaceutical Council, and prescribers are bound by the same professional standards that apply to all UK prescribing. The second is that compounded creams are reserved for unusual or experimental cases. They aren’t; they’re a long-established part of UK pharmacy, used routinely in pain medicine, dermatology, palliative care, and the management of complex chronic illness.

There’s also an honest conversation to be had about cost. Compounded creams are generally more expensive than off-the-shelf products, because each prescription is mixed individually rather than mass-produced. Whether that cost is worth paying depends on your specific situation. For patients whose pain has genuinely outgrown standard options, the answer is often yes. For patients who haven’t yet tried first-line options properly, the right answer is usually to optimise those first.

Pain management built around you doesn’t mean choosing the most expensive option. It means choosing the right option, with honest input from a prescriber and a pharmacist who’ll tell you when something simpler would serve you better.

Innovative and new directions in compounded pain creams

The compounded pain cream field is in a productive period. The biggest developments in recent years have been around personalisation and combination prescribing. Pharmacy-based formulation science has improved the penetration profiles of many compounded bases, and more prescribers in the UK are now confident combining two or three actives in a single cream rather than asking patients to apply multiple products.

For patients with chronic neuropathic pain or pain in the context of conditions like fibromyalgia or hypermobility, some prescribers also consider low-dose naltrexone (LDN) as part of a wider plan. LDN is an oral medicine rather than a compounded cream, but it sits in the same broader landscape of personalised, evidence-informed pain management for patients whose pain doesn’t fit standard frameworks. Fibromyalgia support, personalised and community-led, often involves more than one medicine.

The other shift worth flagging is around digital prescribing pathways. Online consultations with UK-qualified prescribers, supported by free pharmacist follow-up, mean that compounded options are more accessible to patients outside major teaching hospitals than they used to be.

Looking to the future: research and hope

The next decade is likely to see better evidence for combination compounded creams in specific pain syndromes (knee osteoarthritis, post-herpetic neuralgia, chronic localised musculoskeletal pain), more standardised pharmacy formulations across UK compounding pharmacies, and stronger data on long-term safety and tolerability. The British Pain Society and the Faculty of Pain Medicine both highlight personalised topical and multimodal pain management as priority areas for clinical research.

The bigger picture is encouraging. UK pharmacy is moving slowly but genuinely towards better personalisation, more honest conversations about what off-the-shelf products can and can’t do, and wider recognition that pain management has to fit the person rather than the protocol.

How Courier Pharmacy helps with compounded pain relief creams

We treat pain prescribing the way we treat any long-term condition. People often come to us after several rounds of standard products, a frustrating run of GP appointments, or years of quiet self-management. They aren’t the problem. The plan was the problem.

Our approach leans on personalisation and guidance. Every compounded pain cream is supplied after a detailed online consultation reviewed by a UK-qualified prescriber. Our prescriber will ask about your pain history, previous treatments, current medicines, allergies, and goals, often with a follow-up message or call to clarify the picture before writing a personalised compounding prescription. The cream is mixed by our UK-licensed specialist compounding partner and delivered discreetly to your door, with optional 4 to 6 week formulation review built in. Pain management built around you means a real plan, not a faster checkout.

This is also where our brand ambassador, Dr Ada Jex-Cori, comes in. She represents our whole ethos: listening, challenging one-size-fits-all care, and building healthcare that fits the person. Behind her is a real team of pharmacists who do this work every day, and a community of patients we genuinely enjoy hearing from. If a compounded approach isn’t right for you, our team will say so honestly and suggest a better next step, whether that’s optimising your existing standard treatment, arranging a blood panel, or referring back to your GP.

Service highlights

• Online consultation reviewed by a UK-qualified prescriber for every compounded pain cream we supply
• Personalised formulations built around your pain pattern, your previous response to oral and topical analgesics, and any medication sensitivities or allergies
• Common active ingredients available, including diclofenac (up to 5%), lidocaine (2% to 10%), ketoprofen, ibuprofen, piroxicam, amitriptyline, menthol, capsaicin, clonidine, and baclofen.
• Excipient-free and propylene glycol-free bases available for patients with sensitivities, MCAS, or eczema-prone skin
• Combination creams pairing two or three active ingredients to address mixed-mechanism pain in a single application
• Free pharmacist support before and after you order, including a 4 to 6-week formulation review
• Free fortnightly community talks at Insomnia in Derby for anyone navigating persistent pain or other long-term conditions
• 

Frequently asked questions about compounded pain relief creams

What are compounded pain relief creams?

Compounded pain relief creams are personalised topical medicines, prescribed by a UK-qualified prescriber and mixed by a UK-licensed compounding pharmacy specifically for one patient. The prescription specifies the active ingredients, their concentrations, the combination, and the base, based on the individual’s pain pattern, skin, and medical history. The General Pharmaceutical Council regulates UK compounding pharmacies in the same way as any other dispensing pharmacy.

How are compounded pain creams different from Voltarol Emulgel?

Voltarol Emulgel is a commercial off-the-shelf product containing diclofenac at 1.16% (11.6mg/g) in a fixed base. Compounded pain creams allow the prescriber to choose a higher diclofenac concentration (up to 5% or more), combine diclofenac with other actives like lidocaine or amitriptyline, and choose a base that suits your skin. They’re a step up from off-the-shelf, not a replacement for it.

Are compounded pain creams legal in the UK?

Yes. UK compounding pharmacies are regulated by the General Pharmaceutical Council, the same body that regulates all UK pharmacies. Compounded medicines are prescribed by UK-qualified prescribers in line with General Medical Council and Royal Pharmaceutical Society standards. They are an established and legitimate part of UK pharmacy.

When should I consider a compounded pain cream?

A compounded cream is worth considering if you’ve tried Voltarol Emulgel or another off-the-shelf 1.16% topical NSAID consistently for at least two weeks without enough relief, your pain has both inflammatory and neuropathic features, oral NSAIDs aren’t suitable for you, you react to standard topical excipients, you’re trying to reduce oral opioid use, or your pain is localised and well-defined. Speak to a prescriber to confirm.

What active ingredients can be included?

Common active ingredients include diclofenac (up to 5%), lidocaine (2% to 10%), ketoprofen, ibuprofen, piroxicam, amitriptyline, menthol, capsaicin, clonidine, and baclofen. The right combination depends on your pain pattern and previous response. Your prescriber will discuss this during the consultation.

Can you combine more than one active in a single cream?

Yes, and combination creams often work better than single agents for mixed-mechanism pain. Common combinations include diclofenac plus lidocaine for inflammatory plus surface neuropathic pain, or lidocaine plus amitriptyline plus menthol for chronic localised neuropathic pain. The advantage is better pain control with one application rather than several products to track.

Are compounded creams safer than oral painkillers?

For localised pain, topical compounded creams generally produce substantially lower systemic exposure than oral equivalents, which means a more favourable gastrointestinal, renal, and cardiovascular adverse effect profile, as the British National Formulary notes for topical NSAIDs. They aren’t risk-free. Local skin reactions, sensitisation, and (rarely) systemic effects with large-area or prolonged use can still occur. A prescriber’s review is essential.

How long does it take to see results?

Most patients notice some local effect within a few hours of the first application. Inflammatory pain typically improves over the first 1 to 2 weeks of consistent twice-daily or three-times-daily application. Neuropathic pain components often take longer (4 to 6 weeks) to reach steady-state benefit. Your prescriber will recommend a review point to assess response and refine the formulation.

Can I use a compounded cream alongside oral medicines?

Often yes, but it depends on the specific combination. Compounded topical NSAIDs combined with oral NSAIDs can increase the cumulative systemic NSAID load, so this is usually avoided. Compounded creams alongside paracetamol, neuropathic agents, or carefully managed opioids can be a useful multimodal approach. Disclose all your current medicines during consultation so the prescriber can plan safely.

Are compounded creams suitable in pregnancy or breastfeeding?

Many of the active ingredients used in compounded pain creams have specific pregnancy or breastfeeding considerations. Topical NSAIDs are generally avoided in the third trimester, and certain neuropathic agents are not suitable in pregnancy. If you are pregnant, planning a pregnancy, or breastfeeding, tell our prescriber during consultation so the formulation can be tailored or an alternative recommended.

What does the consultation involve?

The online consultation captures your pain history, previous treatments, current medicines, allergies, and goals. A UK-qualified prescriber reviews your answers and may follow up by message or call to clarify the clinical picture. If a compounded approach is appropriate, the prescriber writes a personalised compounding prescription. The cream is mixed by our UK-licensed compounding partner and delivered discreetly to your door.

How do I get a compounded pain cream from Courier Pharmacy?

Complete the online consultation at courierpharmacy.co.uk. A UK-qualified prescriber will review your answers, write a personalised prescription if appropriate, and our compounding partner will mix the cream to specification. Free pharmacist support is available before and after you order, including 4 to 6 week formulation review.

Disclaimer: This article is for general information only and isn’t a substitute for personal medical advice, diagnosis, or treatment. Always check with a GP, pharmacist, or specialist before starting a new supplement if you have a medical condition or take regular medicines.

More than a condition: our community

Healthcare shouldn’t only happen when you’re buying something. That’s why Courier Pharmacy runs free fortnightly drop-in talks and clinics at Insomnia in Derby, every fortnight from 10 am to 12 pm, open to anyone living with persistent pain or another long-term or complex condition. It’s a calm space to ask questions, compare notes, and meet others going through similar experiences. No cost, no pressure, and you’re welcome to bring a friend. Pain management is one of the topics we cover most often. Learn more about our community talks on the courierpharmacy.co.uk community page.

How this content was created

Written by the Courier Pharmacy editorial team and reviewed by a GPhC-registered pharmacist. Grounded in the latest NHS, NICE, BNF and EMC guidance, peer-reviewed studies, and the real questions patients bring to our drop-in clinics in Derby.

References

[1] Courier Pharmacy (n.d.) Compounding pharmacy near me: your guide to personalised medicine in the UK. Available at: https://courierpharmacy.co.uk/compounding-pharmacy-near-me-your-guide-to-personalised-medicine-in-the-uk/ (Accessed: 9 May 2026).